We're excited to welcome Stephan, who joined CordenPharma in June 2024. We'll be discussing his initial impressions at DCAT Week 2025, the company's recent expansion initiatives, strategic partnerships, and the innovative technologies that position CordenPharma as a leader in the industry. Let's discussed these topics to understand how CordenPharma is shaping its future in biopharmaceutical manufacturing.

Welcome to this episode! We Talked to Michaels Quirmbach CEO of CordenPharma and discussed thir ambitious plans and recent strategic moves. Michael will share insights on their record-breaking €1 billion investment over the next three years to expand peptide manufacturing across Europe and the US, including a major greenfield site outside Basel, Switzerland. We'll explore what motivated this huge push, why Basel was chosen, and what sets CordenPharma apart in the competitive GLP-1 space.

Plus, we'll get a sneak peek into other platform expansions and updates on CordenPharma's sustainability and ESG initiatives. Stay tuned!

In this episode, we chat with Matt Minardi from Sterling Pharma about what's really happening in the outsourcing world right now. He shares his thoughts on the current trends, what's driving change in the industry, and how customer needs are evolving when working with CDMOs. We also touch on some of the biggest shifts and what the future might hold for the market.

We're excited to feature Alicia Xaka, Associate Director, Business Development - US & Canada, Procos SpA (CBC Group), a company renowned for its customer-centric approach to custom synthesis and innovative solutions in the API industry. Join us as we explore how Procos is redefining flexibility and responsiveness to meet the evolving needs of emerging therapies.

Corden Pharma: GMP Lipid NanoParticle, investments and expansions.

In this episode we discuss industry trends and small molecules, integrated drugs development and orphan disease development.

We spoke to James Choi - EVP, Chief Marketing Officer and Head of Project Management and Global Public Affairs at Samsung Biologics. In this episode will be discussing sustainability in the pharmaceutical industry as well as having a global footprint in the market.